Clinical Trial

The Effects of Dupilumab on Allergic Contact Dermatitis

Name: The Effects of Dupilumab on Allergic Contact Dermatitis — clinical trial record (NCT03935971)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The aim of this study is to investigate the effects of dupilumab on allergic contact dermatitis.

Protocol Amendment History 1 change

minor Completion pushed: 2026-07-31 -> 2027-03-31 2026-07-17

Trial Details

NCT Number	NCT03935971
Lead Sponsor	Brigham and Women's Hospital Collaborators: Regeneron Pharmaceuticals
Conditions	Allergic Contact Dermatitis
Enrollment	17 participants
Start Date	2019-12-18
Primary Completion	2024-12-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-16